Patent details

EP2785325 Title: PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO [2,3-B]PYRAZIN-2(1H)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE

Basic Information

Publication number:
EP2785325
PCT Application Number:
US2012067172
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127985653
PCT Publication Number:
WO2013082344
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO [2,3-B]PYRAZIN-2(1H)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES DE 7-(6-(2-HYDROXYPROPAN-2-Y1)PYRIDIN-3-YL)-1-((TRANS)-4-MÉTHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO[2,3-B]PYRAZIN-2(1H)-ONE, FORME SOLIDE DE CELLES-CI ET LEURS PROCÉDÉS D'UTILISATION
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN AUS (7-(6-)2-HYDROXYPROPAN-2-YL PYRIDIN-3-YL)-1-(TRANS-)4-METHOXYCYCLOHEXYL-)3,4-DIHYDROPYRAZIN-[2,3-B-] PYRAZIN-2-(1H-)ON, FESTE FORM DARAUS UND VERWENDUNGSVERFAHREN DAFÜR
SPC Number:

Dates

Filing date:
30/11/2012
Grant date:
22/08/2018
EP Publication Date:
08/10/2014
PCT Publication Date:
06/06/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/08/2018
EP B1 Publication Date:
22/08/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/11/2018
Expiration date:
30/11/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/08/2018
 
 

Name:
Signal Pharmaceuticals, LLC
Address:
10300 Campus Point Drive, Suite 100, San Diego, CA 92121, United States (US)

Inventor

1

Name:
XU, Jean
Address:
United States (US)

2

Name:
KLOPFER, Kevin, Joseph
Address:
United States (US)

3

Name:
CONNOLLY, Terrence, Joseph
Address:
United States (US)

4

Name:
GAMBOA, Juan Antonio
Address:
United States (US)

5

Name:
BOERSEN, Nathan
Address:
United States (US)

6

Name:
LEE, Thomas
Address:
China (CN)

7

Name:
MIKLOS, Amanda, Nicole
Address:
United States (US)

8

Name:
HUI, Ho-Wah
Address:
United States (US)

9

Name:
KREILEIN, Matthew Michael
Address:
United States (US)

10

Name:
LI, Ying
Address:
United States (US)

11

Name:
LEONG, William, Wei-Hwa
Address:
United States (US)

12

Name:
COHEN, Benjamin
Address:
United States (US)

13

Name:
MENON, Anil
Address:
United States (US)

Priority

1

Priority Number:
201161566109 P
Priority Date:
02/12/2011
Priority Country:
United States (US)

2

Priority Number:
201261647288 P
Priority Date:
15/05/2012
Priority Country:
United States (US)

3

Priority Number:
201261653439 P
Priority Date:
31/05/2012
Priority Country:
United States (US)

4

Priority Number:
201261670419 P
Priority Date:
11/07/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/20; A61K 9/28; A61K 31/4985; A61P 35/00; C07D 487/04;

Publication

European Patent Bulletin

Issue number:
201834
Publication date:
22/08/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2019 Outgoing Correspondence 1